Advertisement

Contamination of healthcare environment by carbapenem-resistant Acinetobacter baumannii

      Abstract

      Acinetobacter baumannii is frequently found on floors, devices, and environmental sites in hospitals and can survive for prolonged periods and accumulate resistance determinants. The infection and presence of carbapenem-resistant A. baumannii (CRAB) in patients is associated with increased mortality, severe clinical outcomes, and longer lengths of stay at hospitals. This review addresses contamination by CRAB in corporal surfaces of patients and healthcare workers and environmental sites at healthcare-related settings. We summarized published data during the last decade on potential reservoirs for CRAB, including contamination frequency and the involved resistance mechanisms, and some measures associated with the elimination of CRAB from hospital surfaces.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Peleg A.Y.
        • Seifert H.
        • Paterson D.L.
        Acinetobacter baumannii: emergence of a successful pathogen.
        Clin Microbiol Rev. 2008; 21: 538-582
        • Liou M.L.
        • Chen K.H.
        • Yeh H.L.
        • et al.
        Persistent nasal carriers of Acinetobacter baumannii in long-term-care facilities.
        Am J Infect Control. 2017; 45: 723-727
        • Kempf M.
        • Rolain J.M.
        Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
        Int J Antimicrob Agents. 2012; 39: 105-114
        • Munoz-Price L.S.
        • Arheart K.
        • Nordmann P.
        • et al.
        Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital.
        Crit Care Med. 2013; 41: 2733-2742
        • Butler D.A.
        • Biagi M.
        • Tan X.
        • et al.
        Multidrug resistant Acinetobacter baumannii: resistance by any other name would still be hard to treat.
        Curr Infect Dis Rep. 2019; 21: 46
        • Ramirez M.S.
        • Bonomo R.A.
        • Carbapenemases T.M.E.
        Transforming Acinetobacter baumannii into a yet more dangerous menace.
        Biomolecules. 2020; 10: 720
        • Nordmann P.
        • Poirel L.
        Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria.
        Clin Infect Dis. 2019; 69 (Suppl 7): S521-S528
        • Castanheira M.
        • Simner P.J.
        • Bradford PA.
        Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection.
        JAC Antimicrob Resist. 2021; 3: dlab092
        • Sawa T.
        • Kooguchi K.
        • Moriyama K.
        Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance.
        J Intensiv Care. 2020; 8: 13
        • Cicek A.C.
        • Saral A.
        • Iraz M.
        • et al.
        OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital.
        Clin Microbiol Infect. 2014; 20: 410-415
        • Al-Hassan L.
        • Elbadawi H.
        • Osman E.
        • et al.
        Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii from Khartoum state, Sudan.
        Front Microbiol. 2021; 12: 628736
        • Zeka A.N.
        • Poirel L.
        • Sipahi O.R.
        • et al.
        GES-type and OXA-23 carbapenemase-producing Acinetobacter baumannii in Turkey.
        J Antimicrob Chemother. 2014; 69: 1145-1146
        • Bogaerts P.
        • Naas T.
        • El Garch F.
        • et al.
        GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.
        Antimicrob Agents Chemother. 2010; 54: 4872-4878
        • Cai Y.
        • Chai D.
        • Wang R.
        • et al.
        Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
        J Antimicrob Chemother. 2012; 67: 1607-1615
        • Potron A.
        • Poirel L.
        • Nordmann P.
        Emerging broad-spectrum resistance in pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology.
        Int J Antimicrob Agents. 2015; 45: 568-585
        • Savov E.
        • Trifonova A.
        • Kovachka K.
        • et al.
        Antimicrobial in vitro activities of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin against multidrug-resistant Acinetobacter baumannii and pseudomonas aeruginosa - a pilot Bulgarian study.
        Infect Dis. 2019; 51 (Lond11-12): 870-873
      1. World Health Organization. Classifying health workers: mapping occupations to the international standard classification. 2010. Available at: https://www.who.int/hrh/statistics/Health_workers_classification.pdf. Accessed March 26, 2022.

        • Ayobami O.
        • Willrich N.
        • Harder T.
        • et al.
        The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, eastern Mediterranean and Africa: a systematic review and meta-analysis.
        Emerg Microbes Infect. 2019; 8: 1747-1759
        • Centers for Disease Control and Prevention
        Antibiotic Resistance Threats in the United States, 2019.
        Centers for Disease Control and Prevention, Atlanta, GA2019
        • Cheon S.
        • Kim M.J.
        • Yun S.J.
        • et al.
        Controlling endemic multidrug-resistant Acinetobacter baumannii in intensive care units using antimicrobial stewardship and infection control.
        Korean J Intern Med. 2016; 31: 367-374
        • Flamm R.K.
        • Shortridge D.
        • Castanheira M.
        • et al.
        In vitro activity of minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, stenotrophomonas maltophilia, and burkholderia cepacia complex: results from the SENTRY Antimicrobial surveillance program, 2014 to 2018.
        Antimicrob Agents Chemother. 2019; 63: e01154-19
      2. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017. Available at: http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. Accessed August 1, 2020.

        • Cheng V.C.
        • Chen J.H.
        • So S.Y.
        • et al.
        Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.
        Eur J Clin Microbiol Infect Dis. 2015; 34: 2359-2366
        • Henig O.
        • Weber G.
        • Hoshen M.B.
        • et al.
        Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
        Eur J Clin Microbiol Infect Dis. 2015; 34: 2063-2068
        • Sheng W.H.
        • Liao C.H.
        • Lauderdale T.L.
        • et al.
        A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
        Int J Infect Dis. 2010; 14: e764-e769
        • Bedenić B.
        • Beader N.
        • Godič-Torkar K.
        • et al.
        Nursing home as a reservoir of carbapenem-resistant Acinetobacter baumannii.
        Microb Drug Resist. 2015; 21: 270-278
        • Skowron K.
        • Bauza-Kaszewska J.
        • Kraszewska Z.
        • et al.
        Human skin microbiome: impact of intrinsic and extrinsic factors on skin microbiota.
        Microorganisms. 2021; 9: 543
        • Cruz-López F.
        • Villarreal-Treviño L.
        • Morfin-Otero R.
        • et al.
        Dynamics of colonization in patients with health care-associated infections at step-down care units from a tertiary care hospital in Mexico.
        Am J Infect Control. 2020; 48: 1329-1335
        • Hong K.B.
        • Oh H.S.
        • Song J.S.
        • et al.
        Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a pediatric intensive care unit.
        Pediatr Infect Dis J. 2012; 31: 685-690
        • Brigante G.
        • Migliavacca R.
        • Bramati S.
        • et al.
        Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmA.
        J Med Microbiol. 2012; 61: 653-661
        • Gao J.
        • Zhao X.
        • Bao Y.
        • et al.
        Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
        Burns. 2014; 40: 295-299
        • Cheng V.C.
        • Chen J.H.
        • Ng W.C.
        • et al.
        Emergence of carbapenem-resistant Acinetobacter baumannii in nursing homes with high background rates of MRSA colonization.
        Infect Control Hosp Epidemiol. 2016; 37: 983-986
        • Kanwar A.
        • Domitrovic T.N.
        • Koganti S.
        • et al.
        A cold hard menace: a contaminated ice machine as a potential source for transmission of carbapenem-resistant Acinetobacter baumannii.
        Am J Infect Control. 2017; 45: 1273-1275
        • Molter G.
        • Seifert H.
        • Mandraka F.
        • et al.
        Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a multi-level strategic management approach.
        J Hosp Infect. 2016; 92: 194-198
        • Granzer H.
        • Hagen R.M.
        • Warnke P.
        • et al.
        Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii complex isolates from patients that were injured during the eastern Ukrainian conflict.
        Eur J Microbiol Immunol. 2016; 6 (Bp): 109-117
        • Decousser J.W.
        • Jansen C.
        • Nordmann P.
        • et al.
        Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013.
        EuroSurveill. 2013; 18
        • Mammina C.
        • Bonura C.
        • Vivoli A.R.
        • et al.
        Co-colonization with carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii in intensive care unit patients.
        Scand J Infect Dis. 2013; 45: 629-634
        • Martins N.
        • Martins I.S.
        • de Freitas W.V.
        • et al.
        Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
        Microb Drug Resist. 2013; 19: 216-223
        • Neves F.C.
        • Clemente W.T.
        • Lincopan N.
        • et al.
        Clinical and microbiological characteristics of OXA-23- and OXA-143-producing Acinetobacter baumannii in ICU patients at a teaching hospital, Brazil.
        Braz J Infect Dis. 2016; 20: 556-563
        • Ng D.H.L.
        • Marimuthu K.
        • Lee J.J.
        • et al.
        Environmental colonization and onward clonal transmission of carbapenem-resistant Acinetobacter baumannii (CRAB) in a medical intensive care unit: the case for environmental hygiene.
        Antimicrob Resist Infect Control. 2018; 7: 51
        • Ushizawa H.
        • Yahata Y.
        • Endo T.
        • et al.
        A epidemiological investigation of a nosocomial outbreak of multidrug-resistant Acinetobacter baumannii in a critical care center in Japan, 2011-2012.
        Jpn J Infect Dis. 2016; 69: 143-148
        • Saharman Y.R.
        • Karuniawati A.
        • Sedono R.
        • et al.
        Endemic carbapenem-nonsusceptible Acinetobacter baumannii-calcoaceticus complex in intensive care units of the national referral hospital in Jakarta, Indonesia.
        Antimicrob Resist Infect Control. 2018; 7: 5
        • Metan G.
        • Zarakolu P.
        • Otlu B.
        • et al.
        Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak.
        J Infect Public Health. 2020; 13: 564-570
        • Karaaslan A.
        • Soysal A.
        • Altinkanat Gelmez G.
        • et al.
        Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
        J Hosp Infect. 2016; 92: 67-72
        • Al-Hashem G.
        • Rotimi V.O.
        • Albert M.J.
        Antimicrobial resistance of serial isolates of Acinetobacter baumannii colonizing the rectum of adult intensive care Unit patients in a teaching hospital in Kuwait.
        Microb Drug Resist. 2021; 27: 64-72
        • Uwingabiye J.
        • Lemnouer A.
        • Roca I.
        • et al.
        Clonal diversity and detection of carbapenem resistance encoding genes among multidrug-resistant Acinetobacter baumannii isolates recovered from patients and environment in two intensive care units in a Moroccan hospital.
        Antimicrob Resist Infect Control. 2017; 6: 99
        • Maamar E.
        • Alonso C.A.
        • Ferjani S.
        • et al.
        NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia.
        Int J Antimicrob Agents. 2018; 52: 910-915
        • Al-Hamad A.
        • Pal T.
        • Leskafi H.
        • et al.
        Molecular characterization of clinical and environmental carbapenem resistant Acinetobacter baumannii isolates in a hospital of the Eastern Region of Saudi Arabia.
        J Infect Public Health. 2020; 13: 632-636
        • Shimose L.A.
        • Masuda E.
        • Sfeir M.
        • et al.
        Carbapenem-resistant acinetobacter baumannii: concomitant contamination of air and environmental surfaces.
        Infect Control Hosp Epidemiol. 2016; 37: 777-781
        • Thom K.A.
        • Maragakis L.L.
        • Richards K.
        • et al.
        Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey.
        Infect Control Hosp Epidemiol. 2012; 33: 883-888
        • Munoz-Price L.S.
        • Rosa R.
        • Castro J.G.
        • et al.
        Evaluating the impact of antibiotic exposures as time-dependent variables on the acquisition of carbapenem-resistant Acinetobacter baumannii.
        Crit Care Med. 2016; 44: e949-e956
        • Freire M.P.
        • Villela Soares Oshiro I.C.
        • Bonazzi P.R.
        • et al.
        Surveillance culture for multidrug-resistant gram-negative bacteria: performance in liver transplant recipients.
        Am J Infect Control. 2017; 45: e40-e44
        • Nutman A.
        • Lerner A.
        • Schwartz D.
        • et al.
        Evaluation of carriage and environmental contamination by carbapenem-resistant Acinetobacter baumannii.
        Clin Microbiol Infect. 2016; 22: 949.e5-949.e7
        • Nutman A.
        • Lerner A.
        • Fallach N.
        • et al.
        Likelihood of persistent carriage of carbapenem-resistant Acinetobacter baumannii on readmission in previously identified carriers.
        Infect Control Hosp Epidemiol. 2019; 40: 1188-1190
        • An J.H.
        • Kim Y.H.
        • Moon J.E.
        • et al.
        Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: can it predict and reduce subsequent infections and the use of colistin?.
        Am J Infect Control. 2017; 45: 667-672
        • Liu W.L.
        • Liang H.W.
        • Lee M.F.
        • et al.
        The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit.
        PLoS One. 2014; 9e107975
        • Wang C.H.
        • Li J.F.
        • Huang L.Y.
        • et al.
        Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers.
        Am J Infect Control. 2017; 45: 1086-1090
        • Thatrimontrichai A.
        • Pannaraj P.S.
        • Janjindamai W.
        • et al.
        Intervention to reduce carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
        Infect Control Hosp Epidemiol. 2020; 41: 710-715
        • Apisarnthanarak A.
        • Warren D.K.
        Screening for carbapenem-resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches.
        Clin Infect Dis. 2013; 56: 1057-1059
        • Dettori M.
        • Piana A.
        • Deriu M.G.
        • et al.
        Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit.
        New Microbiol. 2014; 37: 185-191
        • Raro O.H.F.
        • Gallo S.W.
        • Ferreira C.A.S.
        • et al.
        Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit.
        Rev Soc Bras Med Trop. 2017; 50: 167-172
        • Ye D.
        • Shan J.
        • Huang Y.
        • et al.
        A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China.
        BMC Infect Dis. 2015; 15: 179
        • Ho C.M.
        • Ho M.W.
        • Chi C.Y.
        • et al.
        Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.
        Surg Infect (Larchmt). 2013; 14: 43-48
        • Ertürk A.
        • Çiçek A.
        • Gümüş A.
        • et al.
        Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units.
        Ann Clin Microbiol Antimicrob. 2014; 13: 36
        • Salehi B.
        • Goudarzi H.
        • Nikmanesh B.
        • et al.
        Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
        J Infect Chemother. 2018; 24: 515-523
        • Zenati K.
        • Touati A.
        • Bakour S.
        • et al.
        Characterization of NDM-1- and OXA-23-producing Acinetobacter baumannii isolates from inanimate surfaces in a hospital environment in Algeria.
        J Hosp Infect. 2016; 92: 19-26
        • Viana Rel H.
        • dos Santos S.G.
        • Oliveira AC.
        Recovery of resistant bacteria from mattresses of patients under contact precautions.
        Am J Infect Control. 2016; 44: 465-469
        • Yakupogullari Y.
        • Otlu B.
        • Ersoy Y.
        • et al.
        Is airborne transmission of Acinetobacter baumannii possible: a prospective molecular epidemiologic study in a tertiary care hospital.
        Am J Infect Control. 2016; 44: 1595-1599
        • Tang C.Y.
        • Yiu S.M.
        • Kuo H.Y.
        • et al.
        Application of 16S rRNA metagenomics to analyze bacterial communities at a respiratory care centre in Taiwan.
        Appl Microbiol Biotechnol. 2015; 99: 2871-2881
        • Tsiatsiou O.
        • Iosifidis Ε.
        • Katragkou A.
        • et al.
        Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
        Eur J Pediatr. 2015; 174: 65-74
        • Thatrimontrichai A.
        • Apisarnthanarak A.
        Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: what should be considered?.
        J Formos Med Assoc. 2020; 119: 1581-1585
        • Rosa R.
        • Arheart K.L.
        • Depascale D.
        • et al.
        Environmental exposure to carbapenem-resistant Acinetobacter baumannii as a risk factor for patient acquisition of A. baumannii.
        Infect Control Hosp Epidemiol. 2014; 35: 430-433
        • Lim C.J.
        • Cheng A.C.
        • Kennon J.
        • et al.
        Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study.
        J Antimicrob Chemother. 2014; 69: 1972-1980
        • Roy S.
        • Viswanathan R.
        • Singh A.
        • et al.
        Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.
        Eur J Clin Microbiol Infect Dis. 2010; 29: 1495-1500
        • Perencevich E.N.
        • Fisman D.N.
        • Lipsitch M.
        • et al.
        Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.
        Clin Infect Dis. 2004; 38: 1108-1115
        • Choi W.S.
        • Kim S.H.
        • Jeon E.G.
        • et al.
        Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program.
        J Korean Med Sci. 2010; 25: 999-1004
        • Robustillo-Rodela A.
        • Pérez-Blanco V.
        • Espinel Ruiz M.A.
        • et al.
        Successful control of 2 simultaneous outbreaks of OXA-48 carbapenemase-producing Enterobacteriaceae and multidrug-resistant Acinetobacter baumannii in an intensive care unit.
        Am J Infect Control. 2017; 45: 1356-1362
        • Lerner A.O.
        • Abu-Hanna J.
        • Carmeli Y.
        • et al.
        Environmental contamination by carbapenem-resistant Acinetobacter baumannii: the effects of room type and cleaning methods.
        Infect Control Hosp Epidemiol. 2020; 41: 166-171
        • Fan C.Y.
        • Lee W.T.
        • Hsu T.C.
        • et al.
        Effect of chlorhexidine bathing on colonization or infection with Acinetobacter baumannii: a systematic review and meta-analysis.
        J Hosp Infect. 2019; 103: 284-292
        • Mendoza-Olazarán S.
        • Camacho-Ortiz A.
        • Martínez-Reséndez M.F.
        • et al.
        Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates.
        Am J Infect Control. 2014; 42: 874-878
        • Lai N.M.
        • Lai N.A.
        • O’Riordan E.
        • et al.
        Skin antisepsis for reducing central venous catheter-related infections.
        Cochrane Database Syst Rev. 2016; 7: CD010140
        • Lerner A.O.
        • Abu-Hanna J.
        • Carmeli Y.
        • et al.
        Environmental contamination by carbapenem-resistant Acinetobacter baumannii: the effects of room type and cleaning methods.
        Infect Control Hosp Epidemiol. 2020; 41: 166-171
        • Chung Y.K.
        • Kim J.S.
        • Lee S.S.
        • et al.
        Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.
        Am J Infect Control. 2015; 43: 1171-1177
        • Muscarella L.F.
        Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy.
        World J Gastrointest Endosc. 2014; 6: 457-474
        • Ben-Chetrit E.
        • Wiener-Well Y.
        • Lesho E.
        • et al.
        An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital.
        Crit Care. 2018; 22: 319
      3. Centers for Disease Control and Prevention. Management of multidrug-resistant organisms in healthcare settings. 2015. Available at: https://www.cdc.gov/infectioncontrol/guidelines/mdro/prevention-control.html. Accessed August 20, 2020.

        • Cho O.H.
        • Bak M.H.
        • Baek E.H.
        • et al.
        Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective.
        Am J Infect Control. 2014; 42: 976-979
        • Apisarnthanarak A.
        • Pinitchai U.
        • Thongphubeth K.
        • et al.
        A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study.
        Clin Infect Dis. 2008; 47: 760-767